Sleep Medicine Year in Review: 2024
HCPLive
DECEMBER 25, 2024
From FDA approvals to updated guidelines, 2024 brought transformative advancements in sleep medicine, offering new hope for managing complex sleep disorders.
HCPLive
DECEMBER 25, 2024
From FDA approvals to updated guidelines, 2024 brought transformative advancements in sleep medicine, offering new hope for managing complex sleep disorders.
Circulation
DECEMBER 25, 2024
Circulation, Volume 151, Issue 1 , Page 123-124, January 7, 2025.
HCPLive
DECEMBER 25, 2024
A panelist discusses how hypertensive disorders during pregnancy remain a leading cause of maternal mortality worldwide, affecting 5-10% of pregnancies and requiring careful monitoring, early detection, and appropriate medical management to protect both mother and baby.
NEJM Journal Watch - Cardiology
DECEMBER 25, 2024
The ACC proposes a new 5-step process for evaluation and management and defines a 4-stage spectrum of myocarditis.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Journal of Cardiothoracic Surgery
DECEMBER 25, 2024
Graft versus host disease (GVHD) is an autoimmune disease that affects the oral cavity as well as other parts of the body. Oral GVHD occurs in 4583% of cases, and chronic GVHD observed in 3050% of cases usua.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Circulation
DECEMBER 25, 2024
Circulation, Volume 151, Issue 1 , Page 94-97, January 7, 2025.
HCPLive
DECEMBER 25, 2024
Panelists discuss how the PRECISION trial evaluated aprocitentan, a dual endothelin receptor antagonist (ERA), in patients with resistant hypertension taking 3 antihypertensive medications including a diuretic.
Circulation
DECEMBER 25, 2024
Circulation, Volume 151, Issue 1 , Page 4-7, January 7, 2025.
The American Journal of Cardiology
DECEMBER 25, 2024
Publication date: Available online 24 December 2024 Source: The American Journal of Cardiology Author(s): Georges Ephrem
Circulation
DECEMBER 25, 2024
Circulation, Volume 151, Issue 1 , Page 1-3, January 7, 2025.
The American Journal of Cardiology
DECEMBER 25, 2024
Publication date: Available online 24 December 2024 Source: The American Journal of Cardiology Author(s): Ashraf Samhan, Danish Saleh, Ellis Y. Kim, Mo Hu, Kayla Mueller, Abigail Garza, Elizabeth Schormann, Parmeen Bindra, Baljash Cheema, Dominic E. Fullenkamp, Abigail S. Baldridge, Jyothy J. Puthumana, James D.
Circulation
DECEMBER 25, 2024
Circulation, Volume 151, Issue 1 , Page 120-122, January 7, 2025.
The American Journal of Cardiology
DECEMBER 25, 2024
Publication date: Available online 24 December 2024 Source: The American Journal of Cardiology Author(s): Nobuki Matsuna, Shoichi Kuramitsu, Yutaka Tadano, Takuro Sugie, Umihiko Kaneko, Hisanori Yui, Takuya Shimizu, Shigeyoshi Miura, Ken Kobayashi, Daitaro Kanno, Yoshifumi Kashima, Tsutomu Fujita
Physiologically Speaking
DECEMBER 25, 2024
Greetings! Just popping in to say Happy Holidays to all of my readers. I hope this season is a time spent enjoying the company of family and friends, reflecting on the past year, and planning to have a great 2025! In 2024, you all helped grow this newsletter to over 19,000 subscribers—I cannot begin to express how grateful I am for each one of you!
Let's personalize your content